News Stories

From University of Miami: For Carl E. Orringer, M.D., the newest faculty member in the Cardiovascular Division, the move from Cleveland to Miami is a homecoming. Orringer is a triple ’Cane, with a B.A. in chemistry (1970), an M.D. (1974) and a residency at Jackson Memorial Hospital (1977). Thirty-seven years later, he’s back, bringing with him a high-profile cardiovascular disease-prevention program that he developed.

“Everything is coming full circle,” Orringer said. “I feel an allegiance to UM, and bringing the program here is my way of saying thank you.”

The 2013 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw a significant increase — from 2.741 (2012) to 3.587. The Journal is now ranked 53rd out of 254 journals in its category (pharmacology and pharmacy). 

The results of the HPS2-THRIVE study were released in the New England Journal of Medicine on July 17, 2014. Also, appearing in the same edition was a special correspondence from the AIM HIGH investigators concerning further analysis of adverse events, and an editorial addressing both of these publications.